8:34 am Hemispherx Biopharma announces new publication enlarges the understanding of ampligen safety profile across diverse animal species and Focuses on the unique TLR-3 receptor/ampligen interaction
View todays social media effects on HEB
View the latest stocks trending across Twitter. Click to view dashboard
See who Hemispherx is hiring next, click here to view
